Receptabio Is A Clinical Stage Biotechnology Company Based In Brazildedicated To Developing Innovative Immunotherapies For Cancer Treatmentfounded In 2005 Through A Collaboration Between Josafernando Perez And The Ludwig Cancer Research Institutethe Company Focuses On Monoclonal Antibodies And Bioactive Peptides That Target Various Cancers The Company Employs A Unique Research And Development Modelpartnering With Academic Institutionshospitalsand International Research Centersreceptabio Is Committed To Translational Researchbridging The Gap Between Preclinical Studies And Clinical Trialsit Develops Immunomodulatory Monoclonal Antibodies And Bioactive Peptidessuch As Rb4 And Rb9Which Are Designed To Address Tumor Microenvironments And Immune Evasion Mechanismsreceptabio S Leadership Includes Ceo Josafernando Perezwho Has Played A Key Role In Establishing The Company S Partnerships And Securing Funding
No conferences found for this company.
| Company Name | Recepta Biopharma Sa |
| Country |
Brazil
|
| Address | N/A |
| Telephone | N/A |
| N/A |
